Marimastat Completed Phase 3 Trials for Lung Cancers Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00003011Marimastat Following Chemotherapy in Treating Patients With Small Cell Lung Cancer
NCT00002911Marimastat in Treating Patients With Stage III Non-small Cell Lung Cancer